Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 2 institutions in 1 country.
Wineke BakkerDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.
Calinda K E DingenoutsDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.
Kirsten LodderDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.
Karien C WiesmeijerDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.
Alwin de JongDepartment of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.
Kondababu KurakulaDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.ORCID 0000-0002-9830-6344
Hans-Jurgen J MagerSt. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands.
Anke M SmitsDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.ORCID 0000-0002-2443-8547
Margreet R de VriesDepartment of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.ORCID 0000-0002-3648-9130
Paul H A QuaxDepartment of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.ORCID 0000-0002-6853-5760
Marie José T H GoumansDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.ORCID 0000-0001-9344-6746
Leiden University Medical Center · NLSt. Antonius Ziekenhuis · NL
Funding
Dutch Cardiovascular Alliance CVON-PHAEDRA-Impact consortiumDutch Heart Foundation NHS2009B063NIRM FES0908
6 · The paper itself
Abstract
Hereditary hemorrhagic telangiectasia type 1 (HHT1) is a severe vascular disorder caused by mutations in the TGFβ/BMP co-receptor
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
BMP Receptor Inhibition Enhances Tissue Repair in Endoglin Heterozygous Mice. · full record | Socratic